Wednesday's After-Hours Movers

Biodel Inc (NASDAQ: BIOD) +27% - Reported positive preliminary results from Phase 2a clinical trial of BIOD-531.

BIND Therapeutics Inc (NASDAQ: BIND) +22% - Provided clinical update for BIND-014.

NephroGenex Inc (NASDAQ: NRX) +18% - The company received positive advice from the European Medicines Agency Regarding its Phase 3 program with Pyridorin.

Mistras Group Inc (NYSE: MG) +16% - Shares are moving higher following financial results.

Resources Connection, Inc. (NASDAQ: RECN) +6% - Shares are higher following the company’s upbeat second quarter results.

Ultragenyx Pharmaceuticals Inc (NASDAQ: RARE) +4.8%- Announced license of IP related to treatment for Huntington’s disease.

Insulet Corporation (NASDAQ: PODD) -8% - Lowered FY2014 Sales guidance from $292-297 million to $287-289 million vs. $296 million estimate.

WD-40 Company (NASDAQ: WDFC) -5.5% - The company reported first quarter results.

Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) -4.8% - Provided update on Phase 2 clinical trial with Eculizumab.

AmTrust Financial Services Inc (NASDAQ: AFSI) - 3.7% - Announced a three million share offering.

See more from Benzinga

• Tuesday's After-Hours Movers

• Tuesday's Morning Market Movers: Minerva, El Pollo LoCo And More

• Monday's After-Hours Market Movers

© 2015 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.